Literature DB >> 18482370

Axonal dysfunction in the deep white matter in Machado-Joseph disease.

Anelyssa D'Abreu1, Marcondes França, Simone Appenzeller, Iscia Lopes-Cendes, Fernando Cendes.   

Abstract

We evaluated spectroscopy findings at the deep white matter in Machado-Joseph disease (MJD). We obtained brain MRI and single-voxel proton MR spectroscopy (MRS) over the superior-posterior region of the left hemisphere at the level of the corpus callosum in 40 patients (44.6 +/- 2.3 years-old) and 27 controls (31.4 +/- 3.6 years). Four patients were excluded due to poor quality spectra. We observed a decrease in signal intensity of N-acetylaspartate relative to creatine-phosphocreatine signal (NAA/Cr) in MJD compared to control [1.63 +/- 0.41 (1.15-2.76) versus 1.97 +/- .51 (1.50-2.92); U test = 219.0; P < .001]. No statistical difference was observed in choline-containing compounds relative to creatine (Cho/Cr). There was no significant correlation between NAA/Cr and clinical and genetic variables. Due to the younger age of the control group, we performed a secondary analysis in a subgroup of 15 MJD patients matched by age to 15 controls. Matching was performed blindly to MRS results and subject identification, except for age and sex. A statistically significant difference was observed in NAA/Cr ratios (U test = 44.0; P= .004), as well as Cho/Cr levels (U test = 53.0; P= .014). We conclude that the metabolic abnormalities observed in the deep white matter in MJD suggest extensive neuronal and axonal dysfunction in these patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18482370     DOI: 10.1111/j.1552-6569.2008.00260.x

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  11 in total

Review 1.  Toward understanding Machado-Joseph disease.

Authors:  Maria do Carmo Costa; Henry L Paulson
Journal:  Prog Neurobiol       Date:  2011-11-23       Impact factor: 11.685

Review 2.  Machado-Joseph Disease: from first descriptions to new perspectives.

Authors:  Conceição Bettencourt; Manuela Lima
Journal:  Orphanet J Rare Dis       Date:  2011-06-02       Impact factor: 4.123

3.  In Vivo Molecular Signatures of Cerebellar Pathology in Spinocerebellar Ataxia Type 3.

Authors:  Maria do Carmo Costa; Maria Radzwion; Hayley S McLoughlin; Naila S Ashraf; Svetlana Fischer; Vikram G Shakkottai; Patrícia Maciel; Henry L Paulson; Gülin Öz
Journal:  Mov Disord       Date:  2020-07-04       Impact factor: 10.338

4.  MR Imaging in Spinocerebellar Ataxias: A Systematic Review.

Authors:  A Klaes; E Reckziegel; M C Franca; T J R Rezende; L M Vedolin; L B Jardim; J A Saute
Journal:  AJNR Am J Neuroradiol       Date:  2016-05-12       Impact factor: 3.825

5.  Widespread neuronal damage and cognitive dysfunction in spinocerebellar ataxia type 3.

Authors:  Tátila Martins Lopes; Anelyssa D'Abreu; Marcondes Cavalcante França; Clarissa Lin Yasuda; Luiz Eduardo Betting; Adriana Bastos Samara; Gabriela Castellano; Júlio César Somazz; Marcio Luiz Figueredo Balthazar; Iscia Lopes-Cendes; Fernando Cendes
Journal:  J Neurol       Date:  2013-06-18       Impact factor: 4.849

6.  Corticospinal tract involvement in spinocerebellar ataxia type 3: a diffusion tensor imaging study.

Authors:  Bruno Shigueo Yonekura Inada; Thiago Junqueira Ribeiro Rezende; Fernando Vieira Pereira; Lucas Ávila Lessa Garcia; Antônio José da Rocha; Pedro Braga Neto; Orlando Graziani Povoas Barsottini; Marcondes Cavalcante França; José Luiz Pedroso
Journal:  Neuroradiology       Date:  2020-09-02       Impact factor: 2.804

Review 7.  Caring for Machado-Joseph disease: current understanding and how to help patients.

Authors:  Anelyssa D'Abreu; Marcondes C França; Henry L Paulson; Iscia Lopes-Cendes
Journal:  Parkinsonism Relat Disord       Date:  2009-10-06       Impact factor: 4.891

Review 8.  Rating scales and biomarkers for CAG-repeat spinocerebellar ataxias: Implications for therapy development.

Authors:  Meng-Ling Chen; Chih-Chun Lin; Liana S Rosenthal; Puneet Opal; Sheng-Han Kuo
Journal:  J Neurol Sci       Date:  2021-04-01       Impact factor: 3.181

9.  Impaired Oligodendrocyte Maturation Is an Early Feature in SCA3 Disease Pathogenesis.

Authors:  Kristen H Schuster; Annie J Zalon; Hongjiu Zhang; Danielle M DiFranco; Nicholas R Stec; Zaid Haque; Kate G Blumenstein; Amanda M Pierce; Yuanfang Guan; Henry L Paulson; Hayley S McLoughlin
Journal:  J Neurosci       Date:  2022-01-18       Impact factor: 6.709

10.  Broad Influence of Mutant Ataxin-3 on the Proteome of the Adult Brain, Young Neurons, and Axons Reveals Central Molecular Processes and Biomarkers in SCA3/MJD Using Knock-In Mouse Model.

Authors:  Kalina Wiatr; Łukasz Marczak; Jean-Baptiste Pérot; Emmanuel Brouillet; Julien Flament; Maciej Figiel
Journal:  Front Mol Neurosci       Date:  2021-06-17       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.